about
Role of androgens in normal and pathological ovarian functionAndrogen receptor inactivation resulted in acceleration in pubertal mammary gland growth, upregulation of ERα expression, and Wnt/β-catenin signaling in female miceMacronutrient balance, reproductive function, and lifespan in aging mice.The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?Subfertile female androgen receptor knockout mice exhibit defects in neuroendocrine signaling, intraovarian function, and uterine development but not uterine function.Improving fertility preservation for girls and women by coupling oocyte in vitro maturation with existing strategies.Measurement of testosterone by immunoassays and mass spectrometry in mouse serum, testicular, and ovarian extracts.Androgen action in female reproductive physiology.Androgens in polycystic ovary syndrome: lessons from experimental models.Grandmaternal smoke exposure reduces female fertility in a murine model, with great-grandmaternal smoke exposure unlikely to have an effect.Role of androgens in the ovary.Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.Measurement of sex steroids in murine blood and reproductive tissues by liquid chromatography-tandem mass spectrometry.The effects of IGF-I on bovine follicle development and IGFBP-2 expression are dose and stage dependent.Reproductive failure in mice expressing transgenic follicle stimulating hormone is not caused by loss of oocyte quality.Characterizing the neuroendocrine and ovarian defects of androgen receptor-knockout female mice.Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.Female mice haploinsufficient for an inactivated androgen receptor (AR) exhibit age-dependent defects that resemble the AR null phenotype of dysfunctional late follicle development, ovulation, and fertility.Subfertility in androgen-insensitive female mice is rescued by transgenic FSH.Granulosa Cell-Specific Brca1 Loss Alone or Combined with Trp53 Haploinsufficiency and Transgenic FSH Expression Fails to Induce Ovarian Tumors.Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.Defining the Nutritional and Metabolic Context of FGF21 Using the Geometric Framework.Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.Global or Granulosa Cell-Specific Pten Mutations in Combination with Elevated FSH Levels Fail to Cause Ovarian Tumours in Mice.Rising follicle-stimulating hormone levels with age accelerate female reproductive failure.The Role of Central Androgen Receptor Actions in Regulating the Hypothalamic-Pituitary-Ovarian Axis.In-vitro regulation of primordial follicle activation: challenges for fertility preservation strategies.A Hyperandrogenic Environment Causes Intrinsic Defects That Are Detrimental to Follicular Dynamics in a PCOS Mouse ModelExpression of the plasminogen system in the physiological mouse ovary and in the pathological polycystic ovary syndrome (PCOS) stateEvidence from animal models on the pathogenesis of PCOSSteroid profiles by liquid chromatography-mass spectrometry of matched serum and single dominant ovarian follicular fluid from women undergoing IVFAndrogen Receptor Signalling Promotes a Luminal Phenotype in Mammary Epithelial CellsAndrogens and ovarian function: translation from basic discovery research to clinical impactMultigenerational obesity-induced perturbations in oocyte-secreted factor signalling can be ameliorated by exercise and nicotinamide mononucleotideMolecular Mechanisms of Insulin Resistance in Polycystic Ovary Syndrome: Unraveling the Conundrum in Skeletal Muscle?
P50
Q26998185-31D2E271-7FF8-41D2-AFFE-9498FF9379F3Q28244921-988DE0F9-A6B6-467A-A1AA-2445143846A0Q35212651-F263FA7F-2E3A-4712-927C-CBABF8C44825Q36319447-F21AD714-D08A-4E82-85EC-5038BB6BA04BQ36861589-832BF6DA-C332-4B65-B887-DAE59545ED57Q37244723-067C13AA-9B71-467E-AD1F-9BE07E19718EQ37741770-CD03BEA1-D0B4-416C-92F3-A4705A0171D5Q38264589-92585D7A-29B6-4606-A8BA-63BD262EA916Q38728326-B0949742-3171-4E24-8F3C-5E1E17E7A187Q38729416-739C077E-0F85-4A76-95B5-93330ADD7B49Q38840688-AC8B82B9-EA6F-4AD5-913C-E638F6F5E006Q39421830-5871C8C9-6657-4F31-A71A-EB788082E449Q42290703-A21A9AA0-3A2B-4B73-8969-4EFE5AC7A12BQ43166996-56938C32-D039-440A-BB25-5A39D3BC3533Q46973460-EFBC60C2-819D-4640-9B00-7E36A3C2EF21Q47549456-C55ABE70-C227-4907-B39B-79E4B71BC17EQ47950352-C56F64BD-D67C-4C16-8A50-507C746AFA3FQ48601415-D56ABF96-16C1-4155-9FB9-0CBEA37305C3Q48794224-510597CB-73F6-4349-A4DA-8B046A0F39C5Q50884738-1F7D62DB-C583-423C-82C2-AF449873DC35Q50980879-2AB9288E-6470-473F-BB98-A45E3467A10DQ51060397-11D7A247-1572-4839-B41E-4ADDD83E522AQ51278414-20552874-7B90-4822-B0F2-145DBEF8DE45Q51356918-E744A264-BCC3-44BF-8C02-583D52A945E6Q51581725-BE430DC9-4E1E-488A-9606-8E45938D922FQ51751514-72CBDEB3-EDBB-4025-9A80-14762C2C8A65Q52596161-CAC1DA63-A9EB-498C-A8E1-D8ACAD9B5F6DQ52675058-ED651394-6374-4B42-BD10-D7EB51FACEADQ63359553-3DE6C7D1-64F5-420C-8CEA-30A33D8D35D1Q64084844-3AB2757A-8F5F-46FB-83D7-BB689317A02AQ88740322-3CE3E70F-0D26-4A4C-B576-C622FE4DBE54Q90348996-A1D3F73C-C23F-4642-BDFB-9B9036292936Q90900248-133E14F1-CE5E-4BA7-89A4-B9D9C7CFBBF8Q92275190-1E7BAD7C-31BD-4180-BA0C-6113ED80B767Q92515362-AF801FA6-A994-4DCB-B507-CD3C7079B952Q92784115-20D90B38-8BD5-49D3-973A-B3C1C17EFD0D
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kirsty A Walters
@ast
Kirsty A Walters
@en
Kirsty A Walters
@es
Kirsty A Walters
@nl
type
label
Kirsty A Walters
@ast
Kirsty A Walters
@en
Kirsty A Walters
@es
Kirsty A Walters
@nl
prefLabel
Kirsty A Walters
@ast
Kirsty A Walters
@en
Kirsty A Walters
@es
Kirsty A Walters
@nl
P106
P31
P496
0000-0002-1504-9734